WO2005124351A8 - A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water - Google Patents

A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water

Info

Publication number
WO2005124351A8
WO2005124351A8 PCT/US2005/018936 US2005018936W WO2005124351A8 WO 2005124351 A8 WO2005124351 A8 WO 2005124351A8 US 2005018936 W US2005018936 W US 2005018936W WO 2005124351 A8 WO2005124351 A8 WO 2005124351A8
Authority
WO
WIPO (PCT)
Prior art keywords
parvum
cpv
oocysts
hominis
oocyst
Prior art date
Application number
PCT/US2005/018936
Other languages
French (fr)
Other versions
WO2005124351A2 (en
WO2005124351A3 (en
Inventor
Mark C Jenkins
Kalmia K Kniel
Original Assignee
Us Agriculture
Mark C Jenkins
Kalmia K Kniel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Agriculture, Mark C Jenkins, Kalmia K Kniel filed Critical Us Agriculture
Publication of WO2005124351A2 publication Critical patent/WO2005124351A2/en
Publication of WO2005124351A3 publication Critical patent/WO2005124351A3/en
Publication of WO2005124351A8 publication Critical patent/WO2005124351A8/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A viral symbiont (CPV) of Cryptosporidium parvum and Cryptosporidium hominis sporozoites has been characterized and a CPV capsid protein, CPV40, has been identified as a target for sensitive detection of C. parvum. Recombinant CPV40 was produced in E. coli, purified by affinity chromatography, and used to prepare polyclonal rabbit sera specific for the viral capsid protein. Anti-rCPV40 recognized a 40 kDa and a 30 kDa protein in C. parvum oocysts and appeared to localize to the apical end of the parasite. Anti-rCPV40 serum was capable of detecting as few as one C. parvum or C. hominis oocyst in a dot blot assay, the sensitivity being at least 1000-fold greater than sera reactive with total native C. parvum protein or specific for the 41 kDa C. parvum oocyst surface antigen. Water samples were seeded with C parvum oocysts and incubated at 4, 20, or 25 °C for greater than 3 months to determine if CPV levels were correlated with oocyst infectivity and viral particle presence. While sporozoite infectivity declined by more than 75% after 1 month at 25 °C, the CPV signal was similar to that of control samples at 4 °C. By three months at 20 °C, the C. parvum oocysts were found to be non-infectious, but retained a high CPV signal. CPV is an excellent target for sensitive detection of C. parvum and C. hominis oocysts in water, but may persist for an indefinite time after oocysts become non-infectious.
PCT/US2005/018936 2004-06-09 2005-05-31 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water WO2005124351A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86393904A 2004-06-09 2004-06-09
US10/863,939 2004-06-09

Publications (3)

Publication Number Publication Date
WO2005124351A2 WO2005124351A2 (en) 2005-12-29
WO2005124351A3 WO2005124351A3 (en) 2006-04-13
WO2005124351A8 true WO2005124351A8 (en) 2006-12-21

Family

ID=35510371

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/018936 WO2005124351A2 (en) 2004-06-09 2005-05-31 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water

Country Status (1)

Country Link
WO (1) WO2005124351A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102183653A (en) * 2011-03-21 2011-09-14 吉林大学 Cryptosporidium parvum immune colloidal gold detection test paper strip and production method thereof
CN102221619A (en) * 2011-06-07 2011-10-19 吉林大学 ELISA (Enzyme-Linked Immuno Sorbent Assay) detection method and kit of cryptosporidium virus capsid protein antibody
CN110967241B (en) * 2019-12-13 2022-07-29 扬州大学 Dyeing method of Eimeria tenella protoplast

Also Published As

Publication number Publication date
WO2005124351A2 (en) 2005-12-29
WO2005124351A3 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
Hsu et al. CDw150 (SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus
JP5597190B2 (en) Detection kit for highly pathogenic avian influenza H5N1 subtype virus
WO2005124351A3 (en) A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water
Holec-Gąsior et al. A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis
Golkar et al. Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein
Myjak Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis
Gatkowska et al. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model
Montero et al. Babesia divergens apical membrane antigen 1 and its interaction with the human red blood cell
Ord et al. Identification and characterization of the rhoptry neck protein 2 in Babesia divergens and B. microti
Preidis et al. Seropositive human subjects produce interferon gamma after stimulation with recombinant Cryptosporidium hominis gp 15
WO2000049416A3 (en) Receptor assay for detecting an effect test compounds have on a particular membrane receptor
WO2011045056A1 (en) Methods for prrsv detection
KR20110137379A (en) Method for detecting antibody against sith-1 in biological sample
Rombaut et al. A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen
Romero-Pinedo et al. Vaccine type-, age-and past infection-dependence of the humoral response to SARS-CoV-2 spike S protein
Cóceres et al. Evaluation of the antigenic value of recombinant Toxoplasma gondii HSP20 to detect specific immunoglobulin G antibodies in Toxoplasma infected humans
Babaie et al. Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli
Hong-Yan et al. Identification and characterization of the UL24 gene product of herpes simplex virus type 2
Ferris et al. Utility of recombinant integrin αvβ6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease
Lesemann et al. Conditions for the use of protein A in combination with the Derrick method of immuno electron microscopy
Sharma et al. Incidence of Lettuce mosaic virus in lettuce and its detection by polyclonal antibodies produced against recombinant coat protein expressed in Escherichia coli
Verdida et al. Serodiagnosis of Babesia gibsoni infection in dogs by an improved enzyme-linked immunosorbent assay with recombinant truncated P50
Chang et al. Evaluation of Pichia pastoris–Expressed Recombinant Rhoptry Protein 2 of Toxoplasma gondii for Its Application in Diagnosis of Toxoplasmosis
Dias et al. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis
Cox et al. Age-specific seroprevalence to an immunodominant Cryptosporidium sporozoite antigen in a Brazilian population

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase